| Product NDC: | 0615-1536 |
| Proprietary Name: | Cyproheptadine Hydrochloride |
| Non Proprietary Name: | Cyproheptadine Hydrochloride |
| Active Ingredient(s): | 4 mg/1 & nbsp; Cyproheptadine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0615-1536 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA087056 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100108 |
| Package NDC: | 0615-1536-39 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (0615-1536-39) |
| NDC Code | 0615-1536-39 |
| Proprietary Name | Cyproheptadine Hydrochloride |
| Package Description | 30 TABLET in 1 BLISTER PACK (0615-1536-39) |
| Product NDC | 0615-1536 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cyproheptadine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100108 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | CYPROHEPTADINE HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |